These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 26363637)

  • 21. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study.
    Malhotra-Kumar S; Lammens C; Coenen S; Van Herck K; Goossens H
    Lancet; 2007 Feb; 369(9560):482-90. PubMed ID: 17292768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial.
    Skalet AH; Cevallos V; Ayele B; Gebre T; Zhou Z; Jorgensen JH; Zerihun M; Habte D; Assefa Y; Emerson PM; Gaynor BD; Porco TC; Lietman TM; Keenan JD
    PLoS Med; 2010 Dec; 7(12):e1000377. PubMed ID: 21179434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effect of Antibiotic Selection Pressure on the Nasopharyngeal Macrolide Resistome: A Cluster-randomized Trial.
    Keenan JD; Chin SA; Amza A; Kadri B; Nassirou B; Cevallos V; Cotter SY; Zhou Z; West SK; Bailey RL; Porco TC; Lietman TM;
    Clin Infect Dis; 2018 Nov; 67(11):1736-1742. PubMed ID: 29897440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nasopharyngeal flora and drug susceptibility in children with macrolide therapy.
    Iino Y; Sasaki Y; Miyazawa T; Kodera K
    Laryngoscope; 2003 Oct; 113(10):1780-5. PubMed ID: 14520106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of azithromycin as the empiric therapy in children with community-acquired pneumonia who were isolated macrolide resistant Streptococcus pneumoniae from nasopharynx].
    Nariai A; Okitsu N; Inoue M
    Kansenshogaku Zasshi; 2004 Jun; 78(6):490-5. PubMed ID: 15287476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral azithromycin given during labour decreases bacterial carriage in the mothers and their offspring: a double-blind randomized trial.
    Roca A; Oluwalana C; Bojang A; Camara B; Kampmann B; Bailey R; Demba A; Bottomley C; D'Alessandro U
    Clin Microbiol Infect; 2016 Jun; 22(6):565.e1-9. PubMed ID: 27026482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term macrolide treatment for non-cystic fibrosis bronchiectasis in children: a meta-analysis.
    Lee E; Sol IS; Kim JD; Yang HJ; Min TK; Jang GC; Hwang YH; Cho HJ; Suh DI; Kim K; Kim HS; Kim YH; Woo SI; Lee YJ; Jung S; Jeon YH
    Sci Rep; 2021 Dec; 11(1):24287. PubMed ID: 34930997
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Alishlash AS; Atkinson TP; Schlappi C; Leal SM; Waites KB; Xiao L
    Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31488697
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of azithromycin on oropharyngeal carriage of group A Streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus pneumoniae.
    Morita JY; Kahn E; Thompson T; Laclaire L; Beall B; Gherardi G; O'Brien KL; Schwartz B
    Pediatr Infect Dis J; 2000 Jan; 19(1):41-6. PubMed ID: 10643849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrolide resistance rates in respiratory pathogens in Slovenia following reduced macrolide use.
    Cizman M; Beović B; Seme K; Paragi M; Strumbelj I; Müller-Premru M; Cad-Pecar S; Pokorn M
    Int J Antimicrob Agents; 2006 Dec; 28(6):537-42. PubMed ID: 17101264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in nasopharyngeal bacterial flora in children with nonsevere recurrent acute otitis media and chronic otitis media with effusion: implications for management.
    Marchisio P; Claut L; Rognoni A; Esposito S; Passali D; Bellussi L; Drago L; Pozzi G; Mannelli S; Schito G; Principi N
    Pediatr Infect Dis J; 2003 Mar; 22(3):262-8. PubMed ID: 12634589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibility of bacterial pathogens in the oropharynx of healthy school children in Turkey.
    Gazi H; Kurutepe S; Sürücüoğlu S; Teker A; Ozbakkaloglŭ B
    Indian J Med Res; 2004 Nov; 120(5):489-94. PubMed ID: 15591635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High nasopharyngeal carriage of drug resistant Streptococcus pneumoniae and Haemophilus influenzae in North Indian schoolchildren.
    Jain A; Kumar P; Awasthi S
    Trop Med Int Health; 2005 Mar; 10(3):234-9. PubMed ID: 15730507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial.
    Goyal V; Grimwood K; Ware RS; Byrnes CA; Morris PS; Masters IB; McCallum GB; Binks MJ; Smith-Vaughan H; O'Grady KF; Champion A; Buntain HM; Schultz A; Chatfield M; Torzillo PJ; Chang AB
    Lancet Respir Med; 2019 Sep; 7(9):791-801. PubMed ID: 31427252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for the nasopharyngeal carriage of respiratory pathogens by Portuguese children: phenotype and antimicrobial susceptibility of Haemophilus influenzae and Streptococcus pneumoniae.
    Neto AS; Lavado P; Flores P; Dias R; Pessanha MA; Sousa E; Palminha JM; Caniça M; Esperança-Pina J
    Microb Drug Resist; 2003; 9(1):99-108. PubMed ID: 12705689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical study on azithromycin in 10% fine granules and 100mg capsules in the field of pediatrics].
    Motohiro T; Nagai K; Yamada S; Tsumura N; Yamada T; Oda K; Sakata Y; Kato H; Gakuen Y; Imai S; Sasaki H; Morita J; Ikezawa S; Matsuo Y; Yamashita Y; Aramaki M; Araki H; Yasuoka C; Hayashi M; Ono E; Hashimoto N; Kubota K; Kawakami A; Toyoda A; Wada M
    Jpn J Antibiot; 1997 Mar; 50(3):272-97. PubMed ID: 9634360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and antimicrobial resistance profiles of respiratory microbial flora in African children with HIV-associated chronic lung disease.
    Abotsi RE; Nicol MP; McHugh G; Simms V; Rehman AM; Barthus C; Mbhele S; Moyo BW; Ngwira LG; Mujuru H; Makamure B; Mayini J; Odland JØ; Ferrand RA; Dube FS
    BMC Infect Dis; 2021 Feb; 21(1):216. PubMed ID: 33632144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands.
    Bosch AATM; van Houten MA; Bruin JP; Wijmenga-Monsuur AJ; Trzciński K; Bogaert D; Rots NY; Sanders EAM
    Vaccine; 2016 Jan; 34(4):531-539. PubMed ID: 26667610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from patients in primary hospitals in Shanghai from 2007 to 2010].
    Zhou CM; Hu BJ; Gao XD; Bao R; Xie HM; Huang SL; Tao LL; He LX
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):346-50. PubMed ID: 24047808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of flocked nylon swabs and non-flocked rayon swabs for detection of respiratory bacteria in nasopharyngeal carriage in Australian Indigenous children.
    Wigger C; Morris PS; Stevens M; Smith-Vaughan H; Hare K; Beissbarth J; Leach AJ
    J Microbiol Methods; 2019 Feb; 157():47-49. PubMed ID: 30578888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.